Since these inhibitors do not induce apoptosis in other types of AML cells, targeting FLT3-ITD could selectively induce apoptosis in FLT3-ITD AML cells through GSK3β activation-mediated Mcl-1 downregulation. The gene discussed is GSK3B; the disease is acute myeloid leukemia.